Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05003362 · ClinicalTrials.gov registry record · NA

ACT for High Frequency Migraine; A Virtual Mindfulness Intervention

A NA study of Migraine, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT05003362 is a NA study of Migraine that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 75 participants, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05003362, a NA study of Migraine, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

Mindfulness Training specifically for pain to be offered to migraine patients

Conditions Studied

Interventions

  • BEHAVIORAL ACT

Study Locations (1)

Massachusetts

  • Brigham and Womens Hospital - Boston

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2020-10-25
Est. Completion 2021-11-23
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT05003362

The ClinicalTrials.gov registry entry for NCT05003362 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (79% lower). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Migraine appearing as the primary indexed condition, and to 1 intervention - of which ACT is the first listed.

NCT05003362 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05003362 about?

NCT05003362 is a clinical study titled "ACT for High Frequency Migraine; A Virtual Mindfulness Intervention". Mindfulness Training specifically for pain to be offered to migraine patients

What is the current status of trial NCT05003362?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2020-10-25. Estimated completion is 2021-11-23.

What conditions does trial NCT05003362 study?

This clinical trial studies the following conditions: Migraine.

What interventions are being tested in trial NCT05003362?

The interventions under investigation include: ACT (BEHAVIORAL).

Who is sponsoring clinical trial NCT05003362?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05003362 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.